<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Oct4, a member of the POU-domain transcription factor family, has been implicated in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell (<z:chebi fb="11" ids="17437,53115">CSC</z:chebi>)-like properties of various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the precise role of Oct4 in colorectal <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> initiation remains uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>Numerous studies have demonstrated a strong link between <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we demonstrated that Oct4 overexpression enhances <z:chebi fb="11" ids="17437,53115">CSC</z:chebi>-like properties of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>), including sphere formation, cell colony formation, cell migration, invasiveness, and drug resistance </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, putative <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> markers, stemness genes, drug-resistant genes, as well as interleukin (IL)-8 and IL-32 were upregulated </plain></SENT>
<SENT sid="5" pm="."><plain>Microarray-based bioinformatics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> showed higher expression levels of embryonic stem cell-specific genes in cells that overexpressed Oct4 </plain></SENT>
<SENT sid="6" pm="."><plain>Neutralization of either IL-8 or IL-32 with specific antibodies partially blocked the tumorigenic effects induced by either Oct4 overexpression or by the addition of conditioned media from Oct4-overexpressing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, the presence of Oct4-overexpressing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> enhanced the tumorigenic potential of parental <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, these data suggest that IL-8 and IL-32 play a role in regulating the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi>-like properties that promote <z:mp ids='MP_0002006'>tumorigenesis</z:mp> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> in both autocrine and paracrine manners </plain></SENT>
</text></document>